PEMF and Mobility: What Does the Research Show?
Summary: PEMF has been studied for a range of movement-related outcomes, including joint stiffness, range of motion, walking ability, strength, and return of movement after surgery.
The human evidence shows an important distinction:
PEMF sometimes improves how mobile people feel and can improve specific range-of-motion or strength measures in certain clinical settings, but objective improvements in walking speed, gait, chair-rise performance, and broader functional mobility are much less consistent.
That means “better mobility” can describe very different outcomes.
A person may report less stiffness and find daily movement easier without showing a measurable increase in walking speed. Likewise, an isolated increase in knee-extension strength does not necessarily translate into better gait or overall mobility.
Understanding exactly what researchers measured is therefore essential.
HealthyLine is a wellness technology company that develops and sells patent-backed, multi-therapy mat systems incorporating PEMF alongside technologies such as far-infrared heat, heated natural gemstones, and selected red/photon light features. This article examines the research on PEMF, mobility, range of motion, and functional movement as part of HealthyLine’s broader educational research library. For the wider framework used to interpret PEMF evidence, see PEMF Research and Evidence: What Does the Science Show?.
What Does “Mobility” Mean in Clinical Research?
Mobility is not one single endpoint.
Researchers may measure several different things.
Range of motion, or ROM, measures the actual arc through which a joint can move. Cervical rotation, knee flexion, shoulder rotation, and similar measurements can be quantified with tools such as a goniometer.
Stiffness describes the perceived resistance to movement, often after rest. In osteoarthritis research this is commonly measured with WOMAC stiffness scores.
Functional mobility measures the ability to perform real-world movement tasks such as walking, standing from a chair, climbing stairs, or changing position.
Strength-related mobility looks at whether the muscles surrounding a joint can generate greater force.
Gait and walking ability may be tested using timed walking, walking distance, or other movement assessments.
Post-operative mobility recovery measures how quickly a person regains movement after procedures such as total knee replacement.
These endpoints are related, but they are not interchangeable.
Someone can become less stiff without walking faster. Muscle strength can improve without producing better chair-rise performance. And reduced pain can make movement feel easier even if the mechanical range of a joint has not changed.
What Does the Research Show About Range of Motion?
One of the clearest range-of-motion studies involved people with cervical osteoarthritis.
Sutbeyaz and colleagues conducted a randomized, double-blind, sham-controlled trial involving 34 adults with reduced neck mobility and chronic cervical osteoarthritis.
The study is particularly interesting because it used a whole-body PEMF mat, rather than a small localized applicator.
The treatment parameters included:
- a device frequency range of 0.1 to 64 Hz; the specific applied frequency was not reported in the secondary treatment record
- field intensity of approximately 40 μT
- 30-minute sessions
- two sessions per day
- three weeks of treatment
Researchers measured active cervical range of motion with goniometry, along with neck disability and paravertebral muscle spasm.
The active PEMF group showed statistically significant improvements in:
- active cervical ROM
- muscle spasm
- Neck Pain and Disability Scale scores
The sham group did not show the same change.
This is notable because the study measured actual joint movement rather than relying only on pain scores.
It is also unusual within the mobility literature because the delivery format was a full-body mat system.
Does That Mean PEMF Improves Range of Motion Generally?
No.
The cervical osteoarthritis result is encouraging, but the evidence for ROM is still relatively limited.
Most PEMF mobility research does not directly measure degrees of joint movement.
Instead, studies often rely on questionnaires asking whether people find activities easier.
That means the evidence for true measured ROM is narrower than the evidence for perceived improvement in mobility or stiffness.
The cervical study suggests that PEMF can affect active movement in at least one specific setting, but it does not establish that every stiff joint will respond in the same way.
What Does Knee Osteoarthritis Research Show?
Knee osteoarthritis dominates the PEMF mobility literature.
Researchers have examined outcomes including:
- stiffness
- knee strength
- walking speed
- chair-rise performance
- WOMAC physical function
- perceived ability to perform daily activities
The results are mixed.
A 2026 randomized, double-blind, placebo-controlled trial by Lau and colleagues involved 60 adults with mild-to-moderate knee osteoarthritis.
The localized PEMF protocol used:
- 50 Hz
- 1 mT
- 30-minute sessions
- three sessions per week
- eight weeks of treatment
Researchers measured knee-extension and flexion strength, six-meter walking time, 30-second chair stands, and WOMAC function.
At six months, knee-extension peak torque increased substantially more in the PEMF group:
approximately 72% versus 25% in the sham group.
That difference reached statistical significance.
But there were no significant between-group differences in:
- six-meter walking time
- chair-stand repetitions
- WOMAC functional scores
So isolated muscular strength improved, while broader mobility did not.
That is an important example of why mobility should not be reduced to one measurement.
Stronger Muscles Do Not Always Mean Better Mobility
The knee study illustrates a broader biomechanical principle.
Walking, standing, climbing stairs, and changing direction require more than isolated muscle strength.
They also depend on:
- balance
- coordination
- joint mechanics
- pain tolerance
- proprioception
- cardiovascular capacity
- confidence in movement
- multiple muscle groups working together
A dynamometer can detect greater knee-extension force without that change being large enough to affect walking speed.
So when a study reports increased torque, it is reasonable to say strength improved.
It is not automatically reasonable to say overall mobility improved.
What Do Meta-Analyses Show About Physical Function?
The higher-level evidence is also mixed.
A Cochrane systematic review involving nine randomized trials and 636 participants examined electromagnetic-field treatment for osteoarthritis.
Although the review found moderate pain relief, it did not find a statistically significant improvement in physical function over approximately 12 to 26 weeks.
The reported mean difference in physical function was 4.55 points on a 0-to-100 scale, with a confidence interval that crossed the point of no effect.
That finding suggests that symptom relief does not necessarily produce a reliable functional improvement.
However, a 2019 systematic review and meta-analysis by Chen and colleagues focused specifically on knee osteoarthritis and reported a statistically significant improvement in WOMAC physical-function scores.
Across eight randomized controlled trials involving 421 participants, the pooled weighted mean difference was:
-5.28 points, with a 95% confidence interval of -9.45 to -1.11 and p = 0.01.
That analysis therefore supports some improvement in self-reported physical function.
The two findings are not necessarily contradictory.
They use different study sets, populations, timeframes, and outcome combinations.
A 2026 meta-analysis reinforces the distinction: it found time-specific improvements in WOMAC stiffness and daily-activity scores, but no significant improvement in objective functional measures.
Together, these findings highlight an important point: self-reported physical function is not the same thing as objectively measured movement performance.
What Does Research Show About Joint Stiffness?
Stiffness shows positive findings in several osteoarthritis reviews, but the evidence is less consistent than it is for pain. Some meta-analyses report significant improvements in WOMAC stiffness, while others do not.
This matters because stiffness can substantially affect the experience of movement.
People with knee osteoarthritis, for example, may find the first movements after sitting or waking especially difficult.
A reduction in perceived stiffness can make everyday activity feel easier even without a large change in maximum joint angle or walking speed.
The evidence supports stiffness as a meaningful mobility-related endpoint, but not as a uniformly positive PEMF outcome.
But it should not be confused with structural restoration of the joint.
Is Reduced Stiffness the Same as Increased Flexibility?
No.
“Flexibility” usually refers to the extensibility of muscles, tendons, and other soft tissues.
A hamstring becoming more flexible, for example, implies that the muscle-tendon unit can lengthen through a greater range.
The PEMF literature reviewed here contains relatively little direct research on this kind of flexibility.
Most of the evidence instead concerns:
- joint stiffness
- pain-limited movement
- osteoarthritis-related restriction
- post-surgical recovery
- functional disability
So the research is much stronger for joint-related mobility limitations than for general flexibility.
What About Mobility After Knee Replacement?
Post-operative rehabilitation provides a different kind of mobility question.
After total knee arthroplasty, movement can be restricted by pain, joint swelling, inflammation, and acute surgical trauma.
A randomized trial by Adravanti and colleagues examined 33 patients following total knee replacement.
The localized I-ONE PEMF protocol used:
- 75 Hz
- approximately 1.5 mT
- approximately four hours per day
- daily use for 60 days
Patients also received standard post-operative rehabilitation.
At one month, the PEMF group showed significantly better outcomes for knee swelling and functional scores. At three-year follow-up, all treated patients reported walking without limitation or walking aids, compared with 27% of controls who occasionally used walking aids. One study author was affiliated with IGEA Clinical Biophysics, and the trial registry states that IGEA supplied the devices and funded the study.
This is an interesting mobility finding because post-surgical swelling can physically restrict movement.
Reducing that early barrier may help a patient participate more effectively in rehabilitation.
But this is a very different clinical situation from ordinary mobility or stiffness in otherwise healthy adults.
What Does Shoulder Research Show?
Shoulder research provides an important negative result.
A randomized, double-blind, placebo-controlled trial by Galace de Freitas and colleagues studied 56 adults with shoulder impingement syndrome.
The PEMF protocol used:
- 50 Hz
- 20 mT
- 30-minute sessions
- three sessions per week
- three weeks of treatment
Both the active and placebo groups also performed shoulder-strengthening exercises.
Both groups improved substantially from baseline.
But there were no statistically significant differences between active PEMF and placebo in:
- shoulder strength
- functional scores
- pain
The exercise program appears to have driven most of the functional improvement.
This is important because PEMF is often used alongside rehabilitation rather than in isolation.
When an effective exercise program is already producing substantial improvements, an additional modality may or may not provide measurable added value.
Does PEMF Improve Walking Ability?
The evidence is considerably weaker here.
Walking is an objective, multi-system mobility outcome.
Researchers may measure:
- walking speed
- six-meter walk time
- walking distance
- gait performance
The knee osteoarthritis trial described earlier found no significant improvement in six-meter walking time despite a substantial increase in knee-extension torque.
Other reviews also show inconsistent translation from reduced pain or stiffness into measurable gait improvement.
So current research does not support a broad conclusion that PEMF reliably improves gait or walking speed.
What About Chair-Rise Performance?
Chair-rise testing is another useful objective mobility measure.
Standing repeatedly from a chair requires lower-body strength, coordination, balance, and joint tolerance.
In the mild-to-moderate knee osteoarthritis trial, PEMF did not significantly improve 30-second chair-stand repetitions compared with sham treatment.
Again, this occurred despite an improvement in isolated knee-extension torque.
This reinforces the same pattern:
a specific physiological or muscular improvement does not always transfer into better whole-body movement.
What About Low Back Mobility?
PEMF has also been studied in people with non-specific low back pain.
A systematic review by Kull and colleagues, published online in 2023 and in its journal issue in 2025, examined nine randomized controlled trials involving 420 participants.
The included studies used:
- frequencies from about 3 to 50 Hz
- field intensities ranging from 2 mT to 150 mT
- sessions lasting approximately 10 to 30 minutes
Five of the nine studies reported statistically significant improvements in physical function compared with their respective controls.
That provides some support for PEMF as an adjunct in lower-back rehabilitation.
But the review also found substantial heterogeneity in:
- field strength
- frequency
- treatment schedule
- concurrent therapy
- outcome measures
And many studies measured function using questionnaires rather than direct spinal kinematics.
So the evidence is encouraging but not standardized.
What About Upper-Extremity Mobility and Function?
Research outside the knee and spine is much more limited.
A 2016 randomized trial by Ammar involving 84 people with lateral epicondylopathy, commonly called tennis elbow, compared PEMF plus exercise with microcurrent electrical nerve stimulation plus exercise and exercise alone.
The PEMF group showed significant improvements in:
- DASH disability scores
- grip strength
compared with the microcurrent group.
This suggests possible benefits for upper-extremity functional recovery.
However, the study did not report enough PEMF device parameters to make the exposure easy to reproduce or compare with other devices.
That limits how broadly the result can be interpreted.
Why Do Subjective and Objective Mobility Measures Differ?
This is one of the most important themes in the research.
Patient questionnaires measure the lived experience of movement.
Someone may report:
“I can get out of a chair more comfortably.”
That can improve because of:
- less pain
- less stiffness
- less fear of movement
- reduced muscle guarding
- better confidence
An objective mobility test asks something different:
“Can this person actually stand more times in 30 seconds?”
or:
“Can this person walk six meters faster?”
Those outcomes require measurable biomechanical performance.
PEMF research more consistently shows improvement in subjective ease of movement than in strict objective performance.
Neither type of outcome is meaningless.
They simply answer different questions.
Does Less Pain Automatically Mean Better Mobility?
Not necessarily.
Pain can restrict movement because people instinctively avoid positions or activities that hurt.
Reducing discomfort can therefore allow a person to move more freely.
But that does not necessarily mean the underlying mechanical limitation has changed.
For example, cartilage loss, joint deformity, ligament restriction, or severe capsular stiffness will not necessarily disappear just because pain is reduced.
This is why mobility research needs both symptom measures and objective biomechanical measurements.
What Does Preclinical Research Suggest?
Laboratory and animal research has investigated several mechanisms that could theoretically influence mobility.
These include effects on:
- inflammatory signaling
- adenosine receptors
- chondrocyte activity
- extracellular matrix production
- microcirculation
- synovial tissue
- subchondral bone
These findings help explain why researchers study PEMF in osteoarthritis and rehabilitation.
But cellular mechanisms should not be treated as proof of improved human mobility.
A change in inflammatory signaling in a laboratory model does not establish that someone will walk faster or regain greater ROM.
Human movement is a much more complex endpoint.
Why Do PEMF Parameters Matter?
The mobility literature uses extremely different PEMF exposures.
Examples from the reviewed studies include:
Cervical osteoarthritis:
0.1 to 64 Hz, approximately 40 μT, whole-body mat.
Post-knee-replacement rehabilitation:
75 Hz, 1.5 mT, localized knee applicator, four hours per day.
Knee osteoarthritis strength study:
50 Hz, 1 mT, localized application.
Shoulder impingement:
50 Hz, 20 mT, localized treatment.
Low back pain studies:
approximately 3 to 50 Hz and 2 to 150 mT.
Those are very different electromagnetic exposures.
Frequency alone cannot establish that two protocols are equivalent.
Field intensity, coil geometry, waveform, anatomical targeting, session length, and cumulative exposure all matter.
For more detail, see Why PEMF Research Results Depend on Study Parameters.
Where Is the Evidence Strongest?
The strongest mobility-related evidence appears in a few specific areas.
Joint stiffness
Osteoarthritis studies and meta-analyses frequently report reductions in perceived stiffness.
Self-reported daily function
Some trials show improvements in questionnaires measuring the ability to perform everyday tasks.
Cervical range of motion
The whole-body mat study in cervical osteoarthritis found measurable improvements in active neck ROM.
Selected strength measures
Localized knee research has reported significant improvements in extension torque.
Post-operative movement recovery
Research following knee replacement suggests that localized PEMF may improve early rehabilitation-related outcomes such as swelling and functional recovery.
These are meaningful findings, but they represent different aspects of mobility rather than one universal effect.
Where Is the Evidence Weak or Uncertain?
The research is considerably weaker for several broader mobility claims.
Walking speed and gait
Objective walking tests often fail to show significant differences from placebo.
Whole-body functional mobility
There is little evidence showing that PEMF consistently improves complex movement performance across the body.
General flexibility
Direct research on muscle-tendon flexibility is sparse.
Structural restoration of joint movement
The evidence does not establish that PEMF reverses degenerative mechanical changes within joints.
Uniform effects across body regions
Knee and cervical-spine research dominates the evidence. Findings cannot automatically be generalized to hips, ankles, shoulders, hands, or other joints.
Can These Findings Be Applied to Consumer PEMF Mats?
Transferability varies considerably depending on the study.
Most positive mobility studies use localized clinical applicators positioned directly over the affected joint or body region.
Those systems can differ substantially from whole-body mats in:
- field intensity
- coil geometry
- applicator placement
- exposure duration
- waveform
- frequency
- distance from the target tissue
However, the mobility evidence includes one particularly relevant exception.
The Sutbeyaz cervical osteoarthritis trial used a whole-body mat at approximately 40 μT, with 30-minute sessions twice daily. The device was reported to have a frequency range of 0.1 to 64 Hz, although the specific applied frequency was not reported in the secondary treatment record.
That makes its delivery format substantially closer to consumer mat systems than many of the localized orthopedic studies.
Even then, the finding remains specific to:
- cervical osteoarthritis
- the protocol studied
- active cervical ROM
- a small group of 34 participants
It should therefore be interpreted as evidence that mat-style PEMF has been studied for a specific mobility outcome, rather than proof of a universal whole-body mobility effect.
For the broader framework used to judge applicability across devices, see When Can PEMF Research Be Applied to Consumer PEMF Mats?.
What Does the Current Evidence Support?
The human research on PEMF and mobility is promising but highly outcome-specific.
The clearest positive findings involve:
- reduced joint stiffness
- improvements in some self-reported physical-function measures
- improved cervical range of motion in one whole-body mat trial
- improved isolated muscular torque in one knee osteoarthritis study
- selected rehabilitation outcomes after joint surgery
But those findings do not consistently translate into better objective whole-body mobility.
Walking speed, chair-rise performance, gait, and other functional tests frequently show little or no significant advantage over control conditions.
The most accurate conclusion is therefore:
PEMF research suggests that certain protocols may reduce stiffness, improve perceived ease of movement, and improve specific mobility measures in selected clinical populations, but current evidence does not establish that PEMF consistently improves gait, walking performance, general flexibility, or whole-body mobility.
As with other PEMF research areas, the result depends heavily on the condition being studied, the body region, the exact mobility endpoint, and the electromagnetic exposure used.
Selected Research Discussed
Sutbeyaz ST, Sezer N, Koseoglu BF. The effect of pulsed electromagnetic fields in the treatment of cervical osteoarthritis: a randomized, double-blind, sham-controlled trial. Rheumatology International. 2006. DOI: 10.1007/s00296-005-0600-3. PubMed.
Adravanti P, Nicoletti S, Setti S, Ampollini A, de Girolamo L. Effect of pulsed electromagnetic field therapy in patients undergoing total knee arthroplasty: a randomised controlled trial. International Orthopaedics. 2014. DOI: 10.1007/s00264-013-2216-7. PubMed.
Galace de Freitas D, Marcondes FB, Monteiro RL, Rosa SG, Fucs PM, Fukuda TY. Pulsed electromagnetic field and exercises in patients with shoulder impingement syndrome: a randomized, double-blind, placebo-controlled clinical trial. Archives of Physical Medicine and Rehabilitation. 2014. DOI: 10.1016/j.apmr.2013.09.022. PubMed.
Yang X, et al. Effects of Pulsed Electromagnetic Field Therapy on Pain, Stiffness, Physical Function, and Quality of Life in Patients With Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Physical Therapy. 2020. DOI: 10.1093/ptj/pzaa054. PubMed.
Efficacy of pulsed electromagnetic field therapy on pain and physical function in patients with non-specific low back pain: a systematic review. 2023. PubMed.